Guardant Health (NASDAQ:GH) priced its IPO of 12.5M common shares at $19/share for gross proceeds of ~$237.5M.
Underwriters have a 30-day option to purchase up to an additional 1.875M common shares.
Guardant Health’s common stock is expected to begin trading on Nasdaq on October 4, 2018, under the ticker symbol “GH”.
The offering is expected to close on October 9, 2018, subject to the satisfaction of customary closing conditions.
Subscribe for full text news in your inbox